Safe use of sugammadex in long QT syndrome

Anaesthesia and Intensive Care

Volumn 38, Issue 6, 2010, Pages 1138-1139

  Riley, R ^a   Song, J W ^a   Paul, V E ^a   Powell, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; MIDAZOLAM; PROPOFOL; SUGAMMADEX; VECURONIUM;

ADULT; CASE REPORT; DEFIBRILLATOR; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; GENERAL ANESTHESIA; HEART ELECTROPHYSIOLOGY; HEART SURGERY; HUMAN; LETTER; LONG QT SYNDROME; NAUSEA; PAIN; POLYMORPHIC VENTRICULAR TACHYCARDIA;

ADULT; ELECTROCARDIOGRAPHY; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; LONG QT SYNDROME; NEUROMUSCULAR BLOCKADE;

EID: 78650496317     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Kies SJ, Pabelick CM, Hurley HA, White RD, Ackerman MJ. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005; 102:204-210. (Pubitemid 40082857)
2. Ackerman MJ, Clapham DE. Ion channels - basic science and clinical disease. N Engl J Med 1997; 336:1575-1586.
3. de Kam P-J, van Kuijk J, Prohn M, Thomsen T, Peeters P. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study. Clin Drug Investig 2010; 30:599-611.
4. Michaloudis DG, Kanakoudis FS, Xatzikraniotis A, Bischiniotis TS. The effects of midazolam followed by administration of either vecuronium or atracurium on the QT interval in humans. Eur J Anaesthesiol 1995; 12:577-583.
5. Beccaria E, Brun S, Gaita F, Giustetto C, Conti M. [Torsade de pointes during an atropine sulfate test in a patient with congenital long QT syndrome]. Cardiologia 1989; 34:1039-1043.
6. Saarnivaara L, Simola M. Effects of four anticholinesterase- anticholinergic combinations and tracheal extubation on QTc interval of the ECG, heart rate and arterial pressure. Acta Anaesthesiol Scand 1998; 42:460-463. (Pubitemid 28138519)